CCM
RMD icon

Cadence Capital Management’s ResMed RMD Stock Holding History

Cadence Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-34,047
Closed -$1.52M – 607
2014
Q1 		$1.52M Buy
+34,047
New +$1.53M 0.06% 359

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Cadence Capital Management's RMD Position: Q2 2014 in Review

Cadence Capital Management sold out of ResMed (RMD) in Q2 2014, closing a stake of 34,047 shares — an estimated $1.52M sold.

Cadence Capital Management first reported a position in RMD in Q1 2014 and held it in 1 quarter. The position peaked at $1.52M in Q1 2014. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

  • Cadence Capital Management reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
  • Cadence Capital Management sold 34,047 ResMed shares in Q2 2014, an estimated $1.52M.
  • Cadence Capital Management first reported a position in ResMed in Q1 2014 and held it in 1 quarter.
  • Cadence Capital Management's ResMed position peaked at $1.52M in Q1 2014.
  • 312 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.